Studi Clinici aperti all’arruolamento

ELVN-002-003 – “A Phase 1a/1b Study of ELVN-002 Combined with Trastuzumab in Advanced Stage HER2+ Solid tumors, and ELVN-002 Combined with Trastuzumab and Chemotherapy in Advanced Stage HER2+ Breast Cancer or Colorectal Cancer”

Catanzaro – AOU Renato Dulbecco – Presidio Mater Domini
Principal Investigator: Prof. Pierfrancesco Tassone
Per informazioni sull’arruolamento contattare:  clinicaltrials.oncology@unicz.it (Tel: 0961-3647921)